Phico Therapeutics' Grant

Phico Therapeutics raised a round of funding on August 01, 2018. Investors include Innovate UK.

Phico Therapeutics is developing SASPject PT3.8, an antibacterial therapy for the systemic treatment of patients with serious Pseudomonas aeruginosa (P. aeruginosa) infections, which have a high morta…

Articles about Phico Therapeutics' Grant: